Healthtech Startups

NADMED offers laboratory kits and analytical services for quantifying NAD and glutathione metabolites in research and diagnostic applications. The company provides CE-marked diagnostic kits, research-use-only kits, and custom quantification services for researchers and labs studying redox metabolism.

1 investor

Naegis Pharmaceuticals is a drug discovery and development company creating first-in-class small-molecule treatments for serious ophthalmic and inflammatory diseases. Its work targets inflammatory mechanisms, including leukotriene pathways, to develop new therapies for eye diseases.

1 investor

Rylo builds accessibility tools for Deaf and hard of hearing people, providing real-time communication solutions that preserve the richness of speech and integrate sign language research. The company serves the aging, deaf, and hard of hearing communities through dedicated support and community-centered product development.

1 investor

Nagish builds Rylo, an accessibility tool that provides communication support across the hearing spectrum for people who are deaf, hard of hearing, aging, or losing their hearing. The company works with the Deaf and hard of hearing community, audiologists, advocacy groups, and nonprofits, and conducts ongoing sign language research.

1 investor

Nahtlos develops medical electrodes designed for reliable performance in long-term medical applications.

1 investor

Nakamo builds AI companions for medical device manufacturers to monitor technical documentation for consistency, completeness, and traceability within existing systems. The platform helps MedTech teams reduce time spent on documentation cross-checking and compliance work.

1 investor

A firm that guides management and strategy for innovations in outpatient spine surgery.

1 investor

NanoDx develops point-of-care diagnostic devices using nanowire biosensor technology to deliver rapid test results at patient locations, targeting unmet clinical needs globally.

1 investor

Nanodropper makes an FDA-listed, sterile twist-on adaptor that attaches to eyedrop bottles to dispense smaller drops, reducing medication waste and extending bottle life. It serves patients using glaucoma, dry eye, cataract, and myopia eyedrops, as well as optometry and ophthalmology clinics.

1 investor

NANOEGG is a pharmaceutical and cosmetics development company that conducts drug research and development, produces non-pharmaceutical health products and cosmetics, and sells pharmaceutical bases and cosmetic raw materials. The company serves pharmaceutical manufacturers, cosmetics brands, and health product developers in Japan.

1 investor

Nanoflex Robotics is a medical device company developing telerobotic endovascular systems that can be operated remotely to treat critical conditions such as strokes and cardiac arrests. A spin-off from ETH Zurich, it targets hospitals and physicians with the aim of widening access to time-sensitive, life-saving interventions.

1 investor

Nanogen develops hair care products designed to improve hair health and promote hair growth. The company markets its offerings to consumers seeking solutions for hair loss and hair strength.

1 investor

NanoGhost develops a drug targeting platform called Nano-Ghosts (NGs), nanovesicles made from the cell membrane of mesenchymal stem cells that target cancer and inflammation sites and can carry various therapeutic loads. The biotech company's technology originates from research at the Technion – Israel Institute of Technology.

1 investor

A Canadian pharmacy compounding service that prepares customized medications in various dosage forms including capsules, tablets, gummies, creams, and veterinary treatments for patients and animals with specialized pharmaceutical needs.

1 investor

NanoGrow Biotech develops biological therapies based on a single-domain antibody (nanobody) platform, combined with various formulations such as topical, inhaled, injectable, and oral delivery. Its targeted therapies address conditions including psoriasis, asthma, inflammatory bowel disease, and melanoma.

1 investor

Nano Imaging Services is a US-based contract research organization (CRO) with in-house cryo-EM microscopes, providing protein production and cryo-electron microscopy services. It supports structure-based drug design and nanoparticle characterization for drug discovery clients.

1 investor

Implanted drug delivery platform customizable to dose, duration, size and shape.

1 investor

Nanoptima develops drug delivery technologies for ophthalmic applications, focusing on biomaterial-based solutions for retinal and eye diseases. The company draws on deep pharma and biotech expertise to advance formulation science and delivery mechanisms for pharmaceutical treatments.

1 investor

Nanospectra Biosciences is a medical device company developing nanoparticle-based thermal ablation therapy that uses light-activated nanoshells to destroy solid tumors, such as prostate cancer, while sparing healthy tissue. Its technology targets clinical applications in tumor ablation, tissue treatment, and drug delivery.

1 investor

NanoTess is a social enterprise developing catalytic materials to address wound care and skin health challenges, with a focus on making healthcare technologies accessible and affordable for patients and communities globally.

1 investor

Nanotherm Therapeutics develops a thermal ablation method for treating solid tumors, using nanoparticle activation to deliver targeted, contact-less heating in an image-guided, 2-step workflow. The approach is aimed at oncology treatment, delivering nanoparticles via a standard 19G needle and enabling same-day diagnosis and treatment.

1 investor

NAPA is an anesthesia services provider that operates a network of clinical and corporate teams focused on patient care delivery and anesthesia management. The company serves healthcare facilities and operates with nearly 5,000 clinicians and support staff.

1 investor

Naqi Logix develops neural earbuds that detect brain waves, muscle impulses, and facial micro-gestures and convert them into digital signals to control devices hands-free, voice-free, and screen-free. The human-machine interface serves applications across gaming, mobility, accessibility, defense, and first response.

1 investor

Narbis develops an at-home neurofeedback training device using smart glasses that darken when the user becomes distracted, helping individuals practice and improve focus and concentration. The technology builds on NASA research into brainwave-based engagement measurement and is designed for general use in daily activities.

1 investor